Patent details

Basic Information

Publication number:

EP1833821

PCT Application Number:

PCT/IB/2005/053716

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP058022906

PCT Publication Number:

WO/2006/051502

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

SULFAMIDES AS ENDOTHELIN RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES

French Title of Invention:

SULFAMIDES EN TANT QU'ANTAGONISTES DU RÉCEPTEUR D'ENDOTHELINE POUR LE TRAITEMENT DES MALADIES CARDIOVASCULAIRES

German Title of Invention:

SULFAMIDE ALSENDOTHELINREZEPTORANTAGONSITEN ZUR BEHANDLUNG VON HERZKREISLAUFERKRANKUNGEN

SPC Number:

Dates

Filing date:

11/11/2005

Grant date:

30/03/2011

EP Publication Date:

30/03/2011

PCT Publication Date:

18/05/2006

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

19/09/2007

EP B1 Publication Date:

30/03/2011

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

11/11/2014

Expiration date:

11/11/2025

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/11/2005

 

 

Name:

Actelion Pharmaceuticals Ltd.

Address:

Gewerbestrasse 16, 4123 Allschwil, Switzerland (CH)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

11/05/2011

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

BOLLI Martin

Address:

Switzerland (CH)

2

Name:

BOSS Christoph

Address:

Switzerland (CH)

3

Name:

FISCHLI Walter

Address:

Switzerland (CH)

4

Name:

WELLER Thomas

Address:

Switzerland (CH)

5

Name:

CLOZEL Martine

Address:

Switzerland (CH)

Priority

Priority Number:

4/012774

Priority Date:

11/11/2004

Priority Country:

European Patent Office (EPO) (EP)

Classification

Main IPC Class:

C07D 403/12;

Filing date	Document type	Number of pages